![]() |
市場調查報告書
商品編碼
2037380
發酵蛋白市場:預測(至2034年)-按產品類型、原料類型、原料、發酵技術、應用、最終用戶和地區分類的全球分析Fermented Protein Market Forecasts to 2034 - Global Analysis By Product Type, Material Type, Source, Fermentation Technique, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球發酵蛋白市場規模將達到 64 億美元,並在預測期內以 17.0% 的複合年成長率成長,到 2034 年將達到 226 億美元。
發酵蛋白是指生產不含動物源的乳清蛋白和酪蛋白、不含動物源的乳蛋白質、真菌蛋白、單細胞蛋白、用於食品和飲料的發酵植物蛋白原料的方法。這些方法包括:植物來源微生物宿主生產與動物源蛋白性能相當的牛奶和雞蛋蛋白;生質能發酵,即培養真菌和微生物生質能作為完全蛋白質來源;氣體發酵,即把氫氣和二氧化碳轉化為單細胞蛋白;以及傳統的發酵增強型植物蛋白,即透過發酵提高大豆、豌豆和其他豆科植物來源蛋白的消化率和生物利用度。
投資非動物性蛋白質的永續性
機構和消費者對非動物性蛋白質生產技術的投資,旨在應對食品系統永續性、動物福利和資源效率等挑戰,這正推動創業投資公司提供大量資金籌措,從而為技術開發和商業化創造了前所未有的動力。精準發酵蛋白的生產經濟效益顯著,其大規模生產成本與傳統乳蛋白質相當,同時又具備與動物源蛋白相同的功能,這為高階食品和飲料製造商的整個原料採購流程創造了極具吸引力的商業機遇。
發酵蛋白規模化生產成本
在目前的商業規模下,生物反應器培養和微發酵蛋白生產的成本仍然遠高於傳統動物性蛋白質原料的價格。因此,主要在高級產品應用中,永續性和功能性帶來的溢價可以抵消高於傳統替代品的原料成本。要實現蛋白質成本的公平競爭,需要對進一步的生產技術進行大量投資,並達成規模化生產的關鍵里程碑;只有這樣,才能使其在主流食品應用中具有經濟可行性。
乳製品業採用替代蛋白質來源
主要乳製品原料供應商和食品生產商採用發酵乳清蛋白和酪蛋白的計劃,正在為運動營養、嬰幼兒配方奶粉和特種食品等領域開發出檢驗的非動物性乳蛋白質原料,這代表著市場變革性的發展,證明了發酵蛋白在機構採購規模上的商業性可行性。 Perfect Day與領先食品公司建立的商業性許可合作關係,正在為非動物源性發酵乳蛋白質市場的廣泛准入樹立經營模式。
新食品產品的監管核准時間表
歐盟、英國及其他一些監管機構對含有發酵蛋白和生質能發酵蛋白成分的新型食品的核准要求,導致核准流程耗時數年。這不僅延緩了產品進入市場,也為那些旨在實現國際商業規模的發酵蛋白公司帶來了監管投資的不確定性。此外,全球監管法規的不完全協調導致市場准入管道分散,並限制了支撐發酵蛋白技術研發大量投資的全球平台經濟。
新冠疫情期間加工廠爆發的疫情暴露了傳統動物蛋白生產供應鏈的脆弱性,促使食品系統加強對非動物性蛋白質替代品的投資,以增強其韌性。在後疫情時代,食品科技領域的投資加速成長,同時,受環境、社會和治理(管治)因素驅動的機構投資者對食品公司永續性蛋白轉型的日益重視,持續推動著發酵蛋白領域的強勁投資和商業性夥伴關係。
在預測期內,傳統發酵增強型植物蛋白領域預計將佔據最大佔有率。
在預測期內,傳統發酵強化型植物蛋白預計將佔據最大的市場佔有率。這主要歸功於發酵加工大豆、豌豆和其他植物性蛋白質原料已實現成熟的商業化規模,這些原料在豆腐、Tempeh、味噌和發酵植物蛋白機能性食品等領域已獲得消費者認可,共同構成了大規模商業性。
在預測期內,非動物源性乳清蛋白和酪蛋白細分市場預計將呈現最高的複合年成長率。
在預測期內,非動物源乳清蛋白和酪蛋白市場預計將呈現最高的成長率,這主要得益於Perfect Day、Remilk以及其他新興競爭對手對發酵乳蛋白質生產的商業化規模擴張,使得原料成本降至足以在高階運動營養品、嬰幼兒配方奶粉和特種食品領域進行商業性應用的水平。發酵的非動物源乳清蛋白和酪蛋白具有與傳統乳蛋白質相當的功能性能,為永續性的食品生產商提供了“即用型”原料替代方案,從而加速了其市場普及。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有全球最具活力的精準發酵蛋白新創企業生態系統,其中像 Perfect Day、Motif FoodWorks 和 Nature's Fynd 這樣的先鋒企業吸引了全球大部分發酵蛋白創業投資投資;此外,美國致力於製定先進的食品技術法規,從而推動商業產品的上市;而且,美國還擁有來自高階食品和運動營養公司、優先考慮的原料採購項目。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要是因為新加坡和澳洲已推出先進的食品法規結構,與主要市場相比,這些地區能夠透過更快捷的核准流程獲得優質發酵蛋白的核准;日本和韓國擁有傳統的發酵蛋白食品文化,為現代發酵蛋白創新產品的推廣提供了天然基礎;此外,新加坡政府對食品技術的大力投資正在推動區域發酵蛋白商業化中心的形成。
According to Stratistics MRC, the Global Fermented Protein Market is accounted for $6.4 billion in 2026 and is expected to reach $22.6 billion by 2034 growing at a CAGR of 17.0% during the forecast period. Fermented protein refers to novel protein production through precision fermentation using microbial hosts to produce animal-identical dairy and egg proteins, biomass fermentation cultivating fungal and microbial biomass as complete protein food sources, gas fermentation converting hydrogen and carbon dioxide into single-cell protein, and traditional fermentation-enhanced plant proteins where fermentation improves digestibility and bioavailability of soy, pea, and other legume proteins, producing animal-free whey and casein, animal-free egg white, mycoprotein, single-cell protein, and fermented plant protein ingredients for food and beverage applications.
Animal-Free Protein Sustainability Investment
Institutional and consumer investment in animal-free protein production technologies addressing food system sustainability, animal welfare, and resource efficiency imperatives is driving substantial venture capital and corporate fermented protein startup funding creating unprecedented technology development and commercialization momentum. Precision fermentation protein production economics approaching cost parity with conventional dairy protein at scale combined with functional performance matching of animal-identical fermented proteins is creating compelling commercial deployment opportunities across premium food and beverage manufacturer ingredient procurement programs.
Fermented Protein Scale-Up Production Costs
Bioreactor cultivation and precision fermentation protein production costs remaining substantially above commodity animal protein ingredient prices at current commercial scale create viable market positioning primarily in premium product applications where sustainability premium and functional performance justify ingredient cost premiums over conventional alternatives, with protein cost parity requiring substantial additional production technology investment and scale-up milestone achievement before mainstream food application economic viability is reached.
Dairy Industry Alternative Protein Ingredient Adoption
Major dairy ingredient supplier and food manufacturer precision fermentation whey and casein protein adoption programs creating verified animal-free dairy protein ingredients for sports nutrition, infant formula, and specialty food applications represent transformative market development that validates fermented protein commercial viability at institutional procurement scale. Perfect Day's commercial licensing partnerships with major food companies establishes business model precedent enabling broad animal-free fermented dairy protein market access.
Novel Food Regulatory Approval Timelines
Novel food regulatory approval requirements for precision fermentation and biomass fermentation protein ingredients across EU, UK, and multiple national regulatory jurisdictions creating multi-year approval pathway timelines that delay market entry and create regulatory investment uncertainty for fermented protein companies seeking international commercial scale, with incomplete global regulatory harmonization creating market access fragmentation that constrains the global platform economics that justify substantial fermented protein technology development investment.
COVID-19 supply chain vulnerabilities in conventional animal protein production exposed during pandemic processing facility outbreaks created food system resilience motivation for animal-free protein alternative investment. Post-pandemic food technology investment acceleration and growing ESG-motivated institutional food company protein sustainability transition commitment continue generating strong fermented protein sector investment and commercial partnership development momentum.
The traditional fermentation-enhanced plant proteins segment is expected to be the largest during the forecast period
The traditional fermentation-enhanced plant proteins segment is expected to account for the largest market share during the forecast period, due to the established commercial scale of fermentation-processed soy, pea, and other plant protein ingredients with proven consumer acceptance in tofu, tempeh, miso, and fermented plant protein functional food applications that collectively represent the largest installed fermented protein market base. Near-term economics of traditional fermentation plant protein improvement programs are commercially proven at scale unlike more novel precision and biomass fermentation approaches.
The animal-free whey & casein segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the animal-free whey & casein segment is predicted to witness the highest growth rate, driven by commercial scaling of precision fermentation dairy protein production by Perfect Day, Remilk, and emerging competitors reaching ingredient cost levels enabling premium sports nutrition, infant formula, and specialty food application commercial deployment. The identical functional performance of fermented animal-free whey and casein to conventional dairy protein creating drop-in ingredient substitution opportunity for sustainability-motivated food manufacturer procurement transitions accelerates adoption momentum.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most active precision fermentation protein startup ecosystem with pioneering companies including Perfect Day, Motif FoodWorks, and Nature's Fynd attracting the majority of global fermented protein venture capital investment, advanced food technology regulatory engagement enabling commercial product launch, and premium sustainability-motivated food and sports nutrition company ingredient procurement programs.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Singapore and Australia implementing progressive novel food regulatory frameworks enabling precision fermentation protein approval on accelerated timelines versus major market equivalents, Japan and South Korea hosting traditional fermented protein food cultures providing natural adoption foundations for modern fermented protein innovation, and strong government food technology investment in Singapore creating regional precision fermentation commercialization hub development.
Key players in the market
Some of the key players in Fermented Protein Market include Perfect Day Inc., The EVERY Company, Impossible Foods Inc., Motif FoodWorks Inc., Nature's Fynd, ENOUGH, Meati Foods, Quorn Foods, Solar Foods Oy, ADM, Cargill Incorporated, Novozymes A/S, Ginkgo Bioworks Holdings Inc., MycoTechnology Inc., Air Protein Inc., Calysta Inc., Unibio A/S, and Remilk Ltd..
In April 2026, Perfect Day Inc. announced commercial scale animal-free whey protein powder achieving cost equivalence with premium conventional whey protein isolate pricing enabling mainstream sports nutrition brand ingredient transition announcements from three major protein supplement companies.
In March 2026, Meati Foods expanded its mycoprotein whole-cut meat alternative production to 10 million pounds annual capacity with new plant-scale fermentation facility enabling national US grocery chain distribution expansion for its fungi-based protein products.
In December 2025, Solar Foods Oy secured European novel food authorization for its Solein single-cell protein from gas fermentation enabling commercial food ingredient launch with initial partnerships with food manufacturers targeting sustainable protein fortification applications.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.